Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Cited In for PubMed (Select 9362334)

1.

Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.

Hamabe A, Konno M, Tanuma N, Shima H, Tsunekuni K, Kawamoto K, Nishida N, Koseki J, Mimori K, Gotoh N, Yamamoto H, Doki Y, Mori M, Ishii H.

Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15526-31. doi: 10.1073/pnas.1407717111. Epub 2014 Oct 13.

2.

Fibroblast heterogeneity in the cancer wound.

Öhlund D, Elyada E, Tuveson D.

J Exp Med. 2014 Jul 28;211(8):1503-23. doi: 10.1084/jem.20140692. Review.

3.

Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition.

Lee SJ, Kim KH, Park KK.

World J Hepatol. 2014 Apr 27;6(4):207-16. doi: 10.4254/wjh.v6.i4.207. Review.

4.

Epithelial-mesenchymal transition and apoptosis of renal tubular epithelial cells are associated with disease progression in patients with IgA nephropathy.

Yao J, Ke Z, Wang X, Peng F, Li B, Wu R.

Mol Med Rep. 2014 Jul;10(1):39-44. doi: 10.3892/mmr.2014.2179. Epub 2014 Apr 24.

5.

Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.

Ali IH, Brazil DP.

Br J Pharmacol. 2014 Aug;171(15):3620-32. doi: 10.1111/bph.12724. Review.

PMID:
24758361
6.

miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.

Morizane R, Fujii S, Monkawa T, Hiratsuka K, Yamaguchi S, Homma K, Itoh H.

Sci Rep. 2014 Apr 3;4:4578. doi: 10.1038/srep04578.

7.

S100 protein family in human cancer.

Chen H, Xu C, Jin Q, Liu Z.

Am J Cancer Res. 2014 Mar 1;4(2):89-115. eCollection 2014. Review.

8.

Myocardial fibroblast-matrix interactions and potential therapeutic targets.

Goldsmith EC, Bradshaw AD, Zile MR, Spinale FG.

J Mol Cell Cardiol. 2014 May;70:92-9. doi: 10.1016/j.yjmcc.2014.01.008. Epub 2014 Jan 26. Review.

9.

Grape seed extract attenuates arsenic-induced nephrotoxicity in rats.

Zhang J, Pan X, Li N, Li X, Wang Y, Liu X, Yin X, Yu Z.

Exp Ther Med. 2014 Jan;7(1):260-266. Epub 2013 Nov 5.

10.

Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis.

Kong P, Christia P, Saxena A, Su Y, Frangogiannis NG.

Am J Physiol Heart Circ Physiol. 2013 Nov 1;305(9):H1363-72. doi: 10.1152/ajpheart.00395.2013. Epub 2013 Aug 30.

11.

Pathophysiology of acute kidney injury.

Basile DP, Anderson MD, Sutton TA.

Compr Physiol. 2012 Apr;2(2):1303-53. doi: 10.1002/cphy.c110041. Review.

12.

Roles of the Skp2/p27 axis in the progression of chronic nephropathy.

Suzuki S, Ohashi N, Kitagawa M.

Cell Mol Life Sci. 2013 Sep;70(18):3277-87. doi: 10.1007/s00018-012-1232-x. Epub 2012 Dec 20. Review.

13.

A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat.

Gilbert RE, Zhang Y, Williams SJ, Zammit SC, Stapleton DI, Cox AJ, Krum H, Langham R, Kelly DJ.

PLoS One. 2012;7(10):e47160. doi: 10.1371/journal.pone.0047160. Epub 2012 Oct 10.

14.

Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.

Román-Pérez E, Casbas-Hernández P, Pirone JR, Rein J, Carey LA, Lubet RA, Mani SA, Amos KD, Troester MA.

Breast Cancer Res. 2012 Mar 19;14(2):R51.

15.

Synergistic and multidimensional regulation of plasminogen activator inhibitor type 1 expression by transforming growth factor type β and epidermal growth factor.

Song X, Thalacker FW, Nilsen-Hamilton M.

J Biol Chem. 2012 Apr 6;287(15):12520-8. doi: 10.1074/jbc.M111.338079. Epub 2012 Feb 10.

16.

The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney.

Pulakat L, Demarco VG, Whaley-Connell A, Sowers JR.

Cardiorenal Med. 2011;1(2):102-112. Epub 2011 Apr 15.

17.

PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy.

Ardite E, Perdiguero E, Vidal B, Gutarra S, Serrano AL, Muñoz-Cánoves P.

J Cell Biol. 2012 Jan 9;196(1):163-75. doi: 10.1083/jcb.201105013. Epub 2012 Jan 2.

18.

Transcriptional networks in epithelial-mesenchymal transition.

Venkov C, Plieth D, Ni T, Karmaker A, Bian A, George AL Jr, Neilson EG.

PLoS One. 2011;6(9):e25354. doi: 10.1371/journal.pone.0025354. Epub 2011 Sep 30.

19.

Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases.

Chao Y, Wu Q, Acquafondata M, Dhir R, Wells A.

Cancer Microenviron. 2012 Apr;5(1):19-28. doi: 10.1007/s12307-011-0085-4. Epub 2011 Sep 3.

20.

Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.

Wang D, Dai C, Li Y, Liu Y.

Kidney Int. 2011 Dec;80(11):1159-69. doi: 10.1038/ki.2011.255. Epub 2011 Aug 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk